Express Scripts 1999 drug trend report: Seniors hit hardest by record 17.4-Percent prescription drug spending increase

e average seven prescriptions per year consumed by those younger than 65. The per-member-per-year cost difference between the two age groups was even greater: $1,185 vs. $267.

Also reported were findings, some of the first using pharmacy claims data, on how seniors responded to caps placed on their pharmacy benefit. Researchers found that, compared to seniors who did not exceed their prescription caps, seniors who had exceeded their plan's spending cap were significantly more likely to have stopped taking medicines across the 11 therapy categories most utilized by seniors. These categories were predominantly represented by therapies used to treat chronic conditions such as cardiovascular disease, diabetes, and hypothyroidism.

The risk of discontinuation was greatest among therapy categories used to treat cardiovascular disease, such as calcium channel blockers, antihyperlipidemics, and beta-blockers. Additionally, researchers found that, for a majority of therapy classes, less than half of those who stopped therapy resumed therapy once the benefit became available again the following year.

"Because seniors depend so heavily on prescription drugs, bear some of the highest costs and have such complex utilization patterns, providing them with prescription drug coverage is one of the biggest challenges currently on the pharmacy landscape," said Barrett Toan, chief executive officer of Express Scripts.

"Express Scripts believes there should be a prescription benefit for seniors, either through Medicare or some other initiative, but it should be understandable and simple to administer, and it should encourage cost-effective behavior by the beneficiary," he added.

Release of the Express Scripts 1999 Drug Trend Report and the senior prescription utilization study findings came during the company's annual Outcomes Conference, where more than 700 employer, managed care, medical and pharmacy benefit participants are reviewing the latest developme

Contact: Ryan Soderstrom
Kupper Parker Communications

Page: 1 2 3 4

Related medicine news :

1. New evidence about positive three-tier co-pay performance presented at Express Scripts 2000 Outcomes Conference
2. Tracking trends in cochlear implant complications using a federal database
3. Changing trends in herbal supplement use
4. New figures highlight trends in drug and alcohol misuse
5. Study of trends in celiac disease
6. Different approaches required for monitoring suicide trends
7. Screening for depression at primary level could be next trend in healthcare
8. Study identifies trends in self-referred imaging
9. First quarter prescription drug spending: Generic drugs slow upward trend
10. Why trends in stroke death in 20th century appeared different to death from heart disease
11. CDC reports latest syphilis trends in United States

Post Your Comments:

(Date:11/27/2015)... ... November 27, 2015 , ... ... convenient way to dispense prescription medications at home, so he invented the patent-pending ... monitor and dispense prescription medications. In doing so, it could help to prevent ...
(Date:11/27/2015)... ... 2015 , ... MPWH, the No.1 Herpes-only dating community in the world, revealed that over 50% ... More than 3.7 billion people under the age of 50 – or 67% of the ... first global estimates of HSV-1 infection . , "The data shocks us highly!" said ...
(Date:11/27/2015)... ... November 27, 2015 , ... Keeping in mind challenges ... health and wellness consultation, has collaborated with a leading web-based marketplace for extra-curricular ... experienced by parents and bring advice from parenting experts within their reach. As ...
(Date:11/27/2015)... ... November 27, 2015 , ... Indosoft ... announces the incorporation of Asterisk 11 LTS (Long Term Support) into its Q-Suite ... LTS brings Q-Suite 5.10 up-to-date with a version of Asterisk that will receive ...
(Date:11/26/2015)... ... 2015 , ... The Catalent Applied Drug Delivery Institute today ... dose form selection in early phase drug development. The first of these is ... together the UK’s emerging life sciences companies, corporate partners, and investors, at Milton ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... , November 26, 2015 ... "Self Administration of High Viscosity Drugs" ... ) has announced the addition of the ... to their offering. --> Research and ... of the "Self Administration of High Viscosity ...
(Date:11/26/2015)... , November 26, 2015 /PRNewswire/ ... announced the addition of the  "2016 ... the European Cell Surface Marker Testing ... Opportunities"  report to their offering.  ... the addition of the  "2016 Future ...
(Date:11/25/2015)... 25, 2015  Amgen (NASDAQ: AMGN ) today ... with the United States (U.S.) ... biosimilar candidate to Humira ® (adalimumab). Amgen believes ... to the FDA and represents Amgen,s first BLA submission ... Harper , M.D., executive vice president of Research and ...
Breaking Medicine Technology:
Cached News: